{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:38:40Z","timestamp":1794019120437,"version":"4.8.0"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN27220140045C"],"award-info":[{"award-number":["HHSN27220140045C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN75N9301900065"],"award-info":[{"award-number":["HHSN75N9301900065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205228\/Z\/16\/Z"],"award-info":[{"award-number":["205228\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["734584"],"award-info":[{"award-number":["734584"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["IS-HPU-1112-10117"],"award-info":[{"award-number":["IS-HPU-1112-10117"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00517","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T04:30:56Z","timestamp":1585110656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design"],"prefix":"10.3389","volume":"11","author":[{"given":"Krishanthi S.","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzannah","family":"Lant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Turtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(19)32790-4","article-title":"The first local cases of Zika virus in Europe","volume":"394","author":"Brady","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.3390\/insects9040158","article-title":"Effects of the environmental temperature on aedes aegypti and aedes albopictus mosquitoes: a review","volume":"9","author":"Reinhold","year":"2018","journal-title":"Insects"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2231-0762.175416","article-title":"Dengue virus: a global human threat: review of literature","volume":"6","author":"Hasan","year":"2016","journal-title":"J Int Soc Prev Community Dent"},{"key":"B5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ncl.2018.06.003","article-title":"Zika virus and neurologic disease","volume":"36","author":"Reid","year":"2018","journal-title":"Neurol Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12879-019-3908-4","article-title":"Factors associated with the development of Congenital Zika Syndrome: a case-control study","volume":"19","author":"Lima","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrmicro2595","article-title":"Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health","volume":"9","author":"Vasilakis","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/v3091562","article-title":"Dengue\u2013quo tu et quo vadis?","volume":"3","author":"Chen","year":"2011","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/infdis\/jiw099","article-title":"Homotypic dengue virus reinfections in nicaraguan children","volume":"214","author":"Waggoner","year":"2016","journal-title":"J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"MBio"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0003749","DOI":"10.1371\/journal.pntd.0003749","article-title":"The complexity of a dengue vaccine: a review of the human antibody response","volume":"9","author":"Flipse","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","volume":"18","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12879-018-3572-0","article-title":"Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: panacea or pandora's box?","volume":"18","author":"Gunawardana","year":"2018","journal-title":"BMC Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1002726","DOI":"10.1371\/journal.pmed.1002726","article-title":"Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua","volume":"16","author":"Gordon","year":"2019","journal-title":"PLoS Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3201\/eid2508.190113","article-title":"Cross-protection of dengue virus infection against congenital zika syndrome, Northeastern Brazil","volume":"25","author":"Pedroso","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"Turtle","year":"2016","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","article-title":"Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection","volume":"18","author":"Fernandez","year":"2017","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.12688\/f1000research.12271.1","article-title":"The immunology of Zika Virus","volume":"7","author":"Culshaw","year":"2018","journal-title":"F1000Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"Smith","year":"2014","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni0715-785a","article-title":"Corrigendum: a new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","article-title":"Lack of durable cross-neutralizing antibodies against zika virus from dengue virus infection","volume":"23","author":"Collins","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during world war II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","article-title":"Origin0061l antigenic sin in dengue","volume":"32","author":"Halstead","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1084\/jem.20191061","article-title":"Risk of Zika microcephaly correlates with features of maternal antibodies","volume":"216","author":"Robbiani","year":"2019","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1172\/JCI113911","article-title":"Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production","volume":"83","author":"Kurane","year":"1989","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.170.3.763","article-title":"Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity","volume":"170","author":"Kurane","year":"1989","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1128\/JVI.63.12.5086-5091.1989","article-title":"Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes","volume":"63","author":"Bukowski","year":"1989","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"St John","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8(+) T cell response during primary zika virus infection in mice","volume":"21","author":"Elong Ngono","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.182.3.853","article-title":"A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities","volume":"182","author":"Zivny","year":"1995","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.154.3.1287","article-title":"Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities","volume":"154","author":"Livingston","year":"1995","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1128\/JVI.72.5.3999-4004.1998","article-title":"Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection","volume":"72","author":"Mathew","year":"1998","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/icb.2010.61","article-title":"Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive","volume":"89","author":"Friberg","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1371\/journal.pone.0001192","article-title":"High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection","volume":"2","author":"Dong","year":"2007","journal-title":"PLoS ONE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10081","DOI":"10.1128\/JVI.00330-07","article-title":"Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes","volume":"81","author":"Imrie","year":"2007","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e01469","DOI":"10.1128\/JVI.01469-17","article-title":"Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"E480","DOI":"10.3390\/v10090480","article-title":"Improved immune responses against zika virus after sequential dengue and zika virus infection in humans","volume":"10","author":"Delgado","year":"2018","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.163.5.2754","article-title":"Partial agonist effect influences the CTL response to a heterologous dengue virus serotype","volume":"163","author":"Zivny","year":"1999","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/CVI.00069-07","article-title":"Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia","volume":"14","author":"Appanna","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.4049\/jimmunol.176.6.3821","article-title":"T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?","volume":"176","author":"Mongkolsapaya","year":"2006","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.4049\/jimmunol.0903262","article-title":"Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue","volume":"184","author":"Dung","year":"2010","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1128\/JVI.79.9.5665-5675.2005","article-title":"Early T-cell responses to dengue virus epitopes in vietnamese adults with secondary dengue virus infections","volume":"79","author":"Simmons","year":"2005","journal-title":"J Virol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e0006540","DOI":"10.1371\/journal.pntd.0006540","article-title":"Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection","volume":"12","author":"Wijeratne","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/infdis\/jir012","article-title":"Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection","volume":"203","author":"Hatch","year":"2011","journal-title":"J Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1086\/324320","article-title":"Strong HLA class I\u2013restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?","volume":"184","author":"Loke","year":"2001","journal-title":"J Infect Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e01992","DOI":"10.1128\/JVI.01992-17","article-title":"Sustained Specific and cross-reactive T cell responses to zika and dengue virus NS3 in West Africa","volume":"92","author":"Herrera","year":"2018","journal-title":"J Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3389\/fimmu.2018.02225","article-title":"Cross-Reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward zika virus","volume":"9","author":"Lim","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.4049\/jimmunol.1801090","article-title":"Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of zika virus-specific CD8(+) T cells","volume":"201","author":"Grifoni","year":"2018","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a112010","article-title":"Study of Japanese encephalitis virus in Chiangmia Valley, Thailand. VI. Summary and conclusions","volume":"100","author":"Grossman","year":"1974","journal-title":"Am J Epidemiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","article-title":"Clinical and immunological risk factors for severe disease in Japanese encephalitis","volume":"96","author":"Libraty","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-981-10-8727-1_16","article-title":"Animal models for Dengue and Zika vaccine development","volume":"1062","author":"Alves Dos Santos","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design","volume":"187","author":"Weiskopf","year":"2011","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1128\/JVI.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"Weiskopf","year":"2014","journal-title":"J Virol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.imlet.2004.07.006","article-title":"Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection","volume":"95","author":"An","year":"2004","journal-title":"Immunol Lett"},{"key":"B79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.virol.2015.10.006","article-title":"Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model","volume":"487","author":"Amorim","year":"2016","journal-title":"Virology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1128\/JVI.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice","volume":"89","author":"Zellweger","year":"2015","journal-title":"J Virol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ebiom.2017.04.033","article-title":"The role of heterotypic DENV-specific CD8(+)T lymphocytes in an immunocompetent mouse model of secondary dengue virus infection","volume":"20","author":"Talarico","year":"2017","journal-title":"EBioMedicine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E385","DOI":"10.3390\/ijerph15020385","article-title":"Immune responses to dengue and zika viruses-guidance for T cell vaccine development","volume":"15","author":"Roth","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e00900","DOI":"10.1128\/JVI.00900-17","article-title":"CD8(+) T cell immune response in immunocompetent mice during zika virus infection","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3389\/fimmu.2019.01045","article-title":"Mouse models of heterologous flavivirus immunity: a role for cross-reactive T cells","volume":"10","author":"Hassert","year":"2019","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41564-017-0060-z","article-title":"Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice","volume":"3","author":"Jurado","year":"2018","journal-title":"Nat Microbiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1006004","DOI":"10.1371\/journal.ppat.1006004","article-title":"Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl\/6 mice","volume":"12","author":"Manangeeswaran","year":"2016","journal-title":"PLoS Pathog"},{"key":"B89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-019-1566-5","article-title":"Zika virus encephalitis in immunocompetent mice is dominated by innate immune cells and does not require T or B cells","volume":"16","author":"Hayashida","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"cross-reactive dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1128\/JVI.02611-10","article-title":"Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis","volume":"85","author":"Larena","year":"2011","journal-title":"J Virol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15674","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1038\/s41467-019-12295-2","article-title":"Time elapsed between Zika and dengue virus infections affects antibody and T cell responses","volume":"10","author":"Perez-Guzman","year":"2019","journal-title":"Nat Commun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.12932\/AP-100518-0309","article-title":"Dengue vaccine: global development update","author":"Prompetchara","year":"2019","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"a030700","DOI":"10.1101\/cshperspect.a030700","article-title":"Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? there is only one true winner","volume":"10","author":"Halstead","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","article-title":"A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone","volume":"15","author":"Osorio","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B104","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","article-title":"Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study","volume":"18","author":"Saez-Llorens","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/infdis\/jiv258","article-title":"CD8+ T-cell responses in flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate","volume":"212","author":"Chu","year":"2015","journal-title":"J Infect Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e0005584","DOI":"10.1371\/journal.pntd.0005584","article-title":"In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination","volume":"11","author":"Whitehead","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"330ra36","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biotechadv.2017.09.004","article-title":"Zika virus structural biology and progress in vaccine development","volume":"36","author":"Lin","year":"2018","journal-title":"Biotechnol Adv"},{"key":"B110","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"B112","doi-asserted-by":"publisher","first-page":"eaay2736","DOI":"10.1126\/scitranslmed.aay2736","article-title":"DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes","volume":"11","author":"Van Rompay","year":"2019","journal-title":"Sci Transl Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"B114","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.3390\/v10110631","article-title":"Recent advances in Zika virus vaccines","volume":"10","author":"Garg","year":"2018","journal-title":"Viruses"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e01485","DOI":"10.1128\/JVI.01485-18","article-title":"A measles virus-based vaccine candidate mediates protection against zika virus in an allogeneic mouse pregnancy model","volume":"93","author":"Nurnberger","year":"2019","journal-title":"J Virol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0202820","DOI":"10.1371\/journal.pone.0202820","article-title":"Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge","volume":"13","author":"Cox","year":"2018","journal-title":"PLoS ONE"},{"key":"B118","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chom.2019.10.001","article-title":"Adenovirus vector-based vaccines confer maternal-fetal protection against Zika virus challenge in pregnant IFN-alphabetaR(-\/-) mice","volume":"26","author":"Larocca","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B119","doi-asserted-by":"publisher","first-page":"eaax2388","DOI":"10.1126\/sciadv.aax2388","article-title":"NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice","volume":"5","author":"Grubor-Bauk","year":"2019","journal-title":"Sci Adv"},{"key":"B120","doi-asserted-by":"publisher","first-page":"978","DOI":"10.4269\/ajtmh.2011.10-0592","article-title":"Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques","volume":"84","author":"Osorio","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"B121","doi-asserted-by":"publisher","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of Zika vaccine in AG129 mouse model","volume":"7","author":"Sumathy","year":"2017","journal-title":"Sci Rep"},{"key":"B122","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1016\/j.vaccine.2018.04.051","article-title":"Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB\/c mice","volume":"36","author":"Wang","year":"2018","journal-title":"Vaccine"},{"key":"B124","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fcimb.2019.00147","article-title":"Cross-protection against four serotypes of dengue virus in mice conferred by a Zika DNA vaccine","volume":"9","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"15743","DOI":"10.1038\/ncomms15743","article-title":"DNA vaccination protects mice against Zika virus-induced damage to the testes","volume":"8","author":"Griffin","year":"2017","journal-title":"Nat Commun"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/s41467-018-05276-4","article-title":"A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"14769","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fimmu.2014.00452","article-title":"Utility, limitations, and future of non-human primates for dengue research and vaccine development","volume":"5","author":"Sariol","year":"2014","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fimmu.2014.00263","article-title":"A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates","volume":"5","author":"Ambuel","year":"2014","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/erv.10.66","article-title":"MHC-peptide tetramers for the analysis of antigen-specific T cells","volume":"9","author":"Sims","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B131","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jmp.12043","article-title":"The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research","volume":"42","author":"Kanthaswamy","year":"2013","journal-title":"J Med Primatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"S928","DOI":"10.1093\/infdis\/jix540","article-title":"Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development","volume":"216","author":"Osuna","year":"2017","journal-title":"J Infect Dis"},{"key":"B133","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1038\/ncomms12204","article-title":"A rhesus macaque model of Asian-lineage Zika virus infection","volume":"7","author":"Dudley","year":"2016","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"B135","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccines"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2011.11.072","article-title":"Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice","volume":"30","author":"Brewoo","year":"2012","journal-title":"Vaccine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e1003521","DOI":"10.1371\/journal.ppat.1003521","article-title":"Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques","volume":"9","author":"Zust","year":"2013","journal-title":"PLoS Pathog"},{"key":"B138","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"13797","DOI":"10.1128\/JVI.79.21.13797-13799.2005","article-title":"Dengue fever in humanized NOD\/SCID mice","volume":"79","author":"Bente","year":"2005","journal-title":"J Virol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm0316-225","article-title":"Missing link: animal models to study whether Zika causes birth defects","volume":"22","author":"Becker","year":"2016","journal-title":"Nat Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:31:26Z","timestamp":1695954686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":140,"alternative-id":["10.3389\/fimmu.2020.00517"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00517","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]},"article-number":"517"}}